These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9369994)

  • 61. Ischemic core and hypoperfusion volumes predict infarct size in SWIFT PRIME.
    Albers GW; Goyal M; Jahan R; Bonafe A; Diener HC; Levy EI; Pereira VM; Cognard C; Cohen DJ; Hacke W; Jansen O; Jovin TG; Mattle HP; Nogueira RG; Siddiqui AH; Yavagal DR; Baxter BW; Devlin TG; Lopes DK; Reddy VK; de Rochemont Rdu M; Singer OC; Bammer R; Saver JL
    Ann Neurol; 2016 Jan; 79(1):76-89. PubMed ID: 26476022
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hyperglycemia in patients with focal cerebral ischemia after intravenous thrombolysis: influence on clinical outcome and infarct size.
    Els T; Klisch J; Orszagh M; Hetzel A; Schulte-Mönting J; Schumacher M; Lücking CH
    Cerebrovasc Dis; 2002; 13(2):89-94. PubMed ID: 11867881
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tissue plasminogen activator-mediated thrombolysis of cerebral emboli and its effect on hemorrhagic infarction in rabbits.
    Lyden PD; Zivin JA; Clark WA; Madden K; Sasse KC; Mazzarella VA; Terry RD; Press GA
    Neurology; 1989 May; 39(5):703-8. PubMed ID: 2496332
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ethanol plus caffeine (caffeinol) for treatment of ischemic stroke: preclinical experience.
    Aronowski J; Strong R; Shirzadi A; Grotta JC
    Stroke; 2003 May; 34(5):1246-51. PubMed ID: 12690223
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Mechanical thrombectomy in the treatment of acute disturbance of cerebral circulation].
    Pienimäki JP; Ollikainen J; Kähärä V; Seppänen J; Numminen H
    Duodecim; 2013; 129(11):1173-80. PubMed ID: 23819204
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Small but severe residual hypoperfusion relates to symptomatic hemorrhage even after early perfusion improvement in tissue plasminogen activator therapy.
    Abumiya T; Katoh M; Moriwaki T; Yoshino M; Aoki T; Imamura H; Aida T; Nakayama N; Houkin K
    Cerebrovasc Dis; 2012; 34(5-6):446-7. PubMed ID: 23207677
    [No Abstract]   [Full Text] [Related]  

  • 67. Thrombolysis for Acute Ischemic Stroke After Protamine Reversal of Heparin.
    Danoun O; Sachar P; Rajamani K
    Am J Ther; 2018; 25(5):e552-e554. PubMed ID: 29199997
    [No Abstract]   [Full Text] [Related]  

  • 68. Ushering in a new era in stroke care.
    Hosp Technol Ser; 1997 Nov; 16(12):8-9. PubMed ID: 10187280
    [No Abstract]   [Full Text] [Related]  

  • 69. Thrombolysis in acute ischemic stroke.
    Lang W; Domanovits H; Görzer H; Germann P; Gatterbauer E; Segall B
    Acta Anaesthesiol Scand Suppl; 1997; 111():34-7. PubMed ID: 9420947
    [No Abstract]   [Full Text] [Related]  

  • 70. Final Infarct Volume of <10 cm
    Tonetti DA; Gross BA; Desai SM; Jadhav AP; Jankowitz BT; Jovin TG
    World Neurosurg; 2018 Nov; 119():e941-e946. PubMed ID: 30103058
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Stroke: Basic and Clinical.
    Singh TP; Weinstein JR; Murphy SP
    Adv Neurobiol; 2017; 15():281-293. PubMed ID: 28674985
    [TBL] [Abstract][Full Text] [Related]  

  • 72. GM1 reduces infarct volume after focal cerebral ischemia.
    Lazzaro A; Seren MS; Koga T; Zanoni R; Schiavo N; Manev H
    Exp Neurol; 1994 Feb; 125(2):278-85. PubMed ID: 8313942
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Thrombolysis and neuroprotection in cerebral ischemia.
    Gutiérrez M; Díez Tejedor E; Alonso de Leciñana M; Fuentes B; Carceller F; Roda JM
    Cerebrovasc Dis; 2006; 21 Suppl 2():118-26. PubMed ID: 16651822
    [TBL] [Abstract][Full Text] [Related]  

  • 74. NXY-059: a hopeful sign in the treatment of stroke.
    Hess DC
    Stroke; 2006 Oct; 37(10):2649-50. PubMed ID: 16946156
    [No Abstract]   [Full Text] [Related]  

  • 75. [Fibrinolytic treatment with tissue plasminogen activator. Outcomes in clinical practice with a multidisciplinary model of intervention].
    Martínez-Pérez M; Cánovas-Vergé D; Carvajal-Díaz A
    Rev Neurol; 2007 Aug 1-15; 45(3):129-33. PubMed ID: 17661269
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mouse model of in situ thromboembolic stroke and reperfusion.
    Orset C; Macrez R; Young AR; Panthou D; Angles-Cano E; Maubert E; Agin V; Vivien D
    Stroke; 2007 Oct; 38(10):2771-8. PubMed ID: 17702959
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Thrombolytic therapy.
    Collen D; Lijnen HR
    Ann N Y Acad Sci; 1991; 614():259-69. PubMed ID: 1902640
    [No Abstract]   [Full Text] [Related]  

  • 78. The effect of tirilazad mesylate on infarct volume of patients with acute ischemic stroke.
    van der Worp HB; Kappelle LJ; Algra A; Bär PR; Orgogozo JM; Ringelstein EB; Bath PM; van Gijn J; ;
    Neurology; 2002 Jan; 58(1):133-5. PubMed ID: 11781420
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke.
    Alonso de Leciñana M; Gutiérrez M; Roda JM; Carceller F; Díez-Tejedor E
    J Neurol Sci; 2006 Sep; 247(2):121-9. PubMed ID: 16797595
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Can raising cerebral blood flow improve outcome after acute cerebral infarction?
    Grotta JC
    Stroke; 1987; 18(1):264-7. PubMed ID: 3810762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.